Add BrightSurf on Google Email

Researchers image live drug response and resistant ‘pockets’ in pancreatic cancer

A research tool developed at the Garvan Institute has uncovered unprecedented detail about pancreatic cancer drug response and resistance. The molecule AKT, a key driver of cancer growth and spread, is activated in distinct parts of the tumour, including areas of low oxygen supply where it forms pockets of resistance to therapy.

SourceGarvan Institute of Medical Research·JournalScience Advances·TypeExperimental study·DateApr 30, 2023